Literature DB >> 27829511

High Burden of Morbidity and Mortality but Not Growth Failure in Infants Exposed to but Uninfected with Human Immunodeficiency Virus in Tanzania.

Lindsey M Locks1, Karim P Manji2, Roland Kupka3, Enju Liu4, Rodrick Kisenge2, Christine M McDonald5, Said Aboud6, Molin Wang7, Wafaie W Fawzi8, Christopher P Duggan9.   

Abstract

OBJECTIVE: To compare health and growth outcomes in children infected with HIV, children exposed to but uninfected with HIV, and children unexposed to HIV. STUDY
DESIGN: Our cohort included 3554 Tanzanian children enrolled in 2 trials of micronutrient supplementation. Among infants born to mothers infected with HIV, 264 were infected with HIV and 2088 were exposed to but uninfected at 6 weeks of age. An additional 1202 infants were unexposed to HIV. Infants were followed until 18 months of age, death, or loss to follow-up. Morbidity and growth were assessed at monthly nurse visits.
RESULTS: Compared with unexposed infants, hazard ratios (95% CI) for all-cause mortality in infants infected with HIV and infants who were exposed to but uninfected with HIV were 28.99 (14.83-56.66) and 2.79 (1.41-5.53), respectively, after adjusting for demographic and nutritional covariates. Compared with infants unexposed to HIV, infants infected with HIV also had a significantly greater risk of all measured morbidities, while infants who were exposed to but uninfected with HIV were significantly more likely to suffer from cough, fever, unscheduled outpatient visits, and hospitalizations. Infants infected with HIV also were more likely to experience stunting, wasting, and underweight at baseline and during follow-up. Infants exposed to but uninfected with HIV were more likely to be underweight at baseline (adjusted relative risk, 2.05; 95% CI, 1.45-2.89), but on average, experienced slower declines in height-for-age z-score, weight-for-age z-score, and weight-for-height z-score as well as a lower rate of stunting over follow-up, compared with unexposed infants.
CONCLUSION: In addition to preventing and treating HIV infection in infants, prevention-of-mother-to-child-transmission of HIV and child health services should also target children exposed to but uninfected with HIV to improve health outcomes in this vulnerable population. TRIAL REGISTRATION: Clinicaltrials.gov: NCT00197730 and NCT00421668.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; HIV-exposed-uninfected; child health; growth; morbidity; mortality

Mesh:

Year:  2016        PMID: 27829511      PMCID: PMC5183465          DOI: 10.1016/j.jpeds.2016.09.040

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  43 in total

1.  Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

Authors:  Denise L Jacobson; Kunjal Patel; George K Siberry; Russell B Van Dyke; Linda A DiMeglio; Mitchell E Geffner; Janet S Chen; Elizabeth J McFarland; William Borkowsky; Margarita Silio; Roger A Fielding; Suzanne Siminski; Tracie L Miller
Journal:  Am J Clin Nutr       Date:  2011-11-02       Impact factor: 7.045

2.  Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.

Authors:  Kathleen M Powis; Laura Smeaton; Anthony Ogwu; Shahin Lockman; Scott Dryden-Peterson; Erik van Widenfelt; Jean Leidner; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

3.  Daily Zinc but Not Multivitamin Supplementation Reduces Diarrhea and Upper Respiratory Infections in Tanzanian Infants: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Christine M McDonald; Karim P Manji; Rodrick Kisenge; Said Aboud; Donna Spiegelman; Wafaie W Fawzi; Christopher P Duggan
Journal:  J Nutr       Date:  2015-07-22       Impact factor: 4.798

Review 4.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

Review 5.  The HIV-exposed, uninfected African child.

Authors:  Suzanne Filteau
Journal:  Trop Med Int Health       Date:  2009-01-20       Impact factor: 2.622

6.  Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.

Authors:  Heena Brahmbhatt; Godfrey Kigozi; Fred Wabwire-Mangen; David Serwadda; Tom Lutalo; Fred Nalugoda; Nelson Sewankambo; Mohamed Kiduggavu; Maria Wawer; Ronald Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

7.  A randomized trial of multivitamin supplements and HIV disease progression and mortality.

Authors:  Wafaie W Fawzi; Gernard I Msamanga; Donna Spiegelman; Ruilan Wei; Saidi Kapiga; Eduardo Villamor; Davis Mwakagile; Ferdinand Mugusi; Ellen Hertzmark; Max Essex; David J Hunter
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

8.  Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study.

Authors:  Lisa M McNally; Prakash M Jeena; Kavitha Gajee; Stanley A Thula; A Willem Sturm; Sharon Cassol; Andrew M Tomkins; Hoosen M Coovadia; David Goldblatt
Journal:  Lancet       Date:  2007-04-28       Impact factor: 79.321

9.  Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies.

Authors:  Ibironke Olofin; Christine M McDonald; Majid Ezzati; Seth Flaxman; Robert E Black; Wafaie W Fawzi; Laura E Caulfield; Goodarz Danaei
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

Review 10.  The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials.

Authors:  Ethan K Gough; Erica E M Moodie; Andrew J Prendergast; Sarasa M A Johnson; Jean H Humphrey; Rebecca J Stoltzfus; A Sarah Walker; Indi Trehan; Diana M Gibb; Rie Goto; Soraia Tahan; Mauro Batista de Morais; Amee R Manges
Journal:  BMJ       Date:  2014-04-15
View more
  15 in total

1.  Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

Authors:  David R Martinez; Youyi Fong; Shuk Hang Li; Fang Yang; Madeleine F Jennewein; Joshua A Weiner; Erin A Harrell; Jesse F Mangold; Ria Goswami; George R Seage; Galit Alter; Margaret E Ackerman; Xinxia Peng; Genevieve G Fouda; Sallie R Permar
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

2.  Third Trimester Vitamin D Status Is Associated With Birth Outcomes and Linear Growth of HIV-Exposed Uninfected Infants in the United States.

Authors:  Christopher R Sudfeld; Denise L Jacobson; Noé M Rueda; Daniela Neri; Armando J Mendez; Laurie Butler; Suzanne Siminski; Kristy M Hendricks; Claude A Mellins; Christopher P Duggan; Tracie L Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

3.  Critical Role for Monocytes/Macrophages in Rapid Progression to AIDS in Pediatric Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Chie Sugimoto; Kristen M Merino; Atsuhiko Hasegawa; Xiaolei Wang; Xavier A Alvarez; Hiroshi Wakao; Kazuyasu Mori; Woong-Ki Kim; Ronald S Veazey; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

4.  Experiences of Fetal or Infant Loss among Tanzanian Women in HIV Care.

Authors:  Godfrey A Kisigo; Preeti Manavalan; Cody Cichowitz; Brandon A Knettel; Blandina T Mmbaga; Melissa H Watt
Journal:  J Loss Trauma       Date:  2019-04-29

5.  Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana.

Authors:  Deborah Kacanek; Paige L Williams; Gloria Mayondi; Penny Holding; Jean Leidner; Kebaiphe Moabi; Vicki Tepper; Sharon Nichols; Joseph Makhema; Haruna Jibril; Tebogo Madidimalo; Roger Shapiro; Shahin Lockman; Betsy Kammerer
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

Review 6.  Role of Inflammation in Virus Pathogenesis during Pregnancy.

Authors:  Anna Chudnovets; Jin Liu; Harish Narasimhan; Yang Liu; Irina Burd
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

7.  Identifying Infants and Young Children at Risk of Unplanned Hospital Admissions and Clinic Visits in Dar es Salaam, Tanzania.

Authors:  Chris A Rees; Rodrick Kisenge; Karim P Manji; Enju Liu; Wafaie W Fawzi; Christopher P Duggan
Journal:  Pediatr Infect Dis J       Date:  2020-12       Impact factor: 3.806

Review 8.  Vitamin A supplements for reducing mother-to-child HIV transmission.

Authors:  Charles S Wiysonge; Valantine N Ndze; Eugene J Kongnyuy; Muki S Shey
Journal:  Cochrane Database Syst Rev       Date:  2017-09-07

9.  Biomarkers of Systemic Inflammation and Growth in Early Infancy are Associated with Stunting in Young Tanzanian Children.

Authors:  Sana Syed; Karim P Manji; Christine M McDonald; Rodrick Kisenge; Said Aboud; Christopher Sudfeld; Lindsey Locks; Enju Liu; Wafaie W Fawzi; Christopher P Duggan
Journal:  Nutrients       Date:  2018-08-24       Impact factor: 5.717

10.  Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.

Authors:  Yohannes Ejigu; Jeanette H Magnus; Johanne Sundby; Maria Christine Magnus
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.